铜绿假单胞菌喹诺酮耐药菌株中DNA促旋酶突变体的比例。
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
作者信息
Yoshida H, Nakamura M, Bogaki M, Nakamura S
机构信息
Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Osaka, Japan.
出版信息
Antimicrob Agents Chemother. 1990 Jun;34(6):1273-5. doi: 10.1128/AAC.34.6.1273.
Abstract
The proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa was examined by introducing the cloned wild-type Escherichia coli gyrA and gyrB genes. Of 101 spontaneous mutants of P. aeruginosa PAO505, 33 (33%) were found to have gyrA mutations. Among 17 clinical isolates, 12 (71%) had gyrA mutations and 1 (6%) had a gyrB mutation.
摘要
通过导入克隆的野生型大肠杆菌gyrA和gyrB基因，检测了铜绿假单胞菌喹诺酮耐药菌株中DNA促旋酶突变体的比例。在铜绿假单胞菌PAO505的101个自发突变体中，发现33个（33%）有gyrA突变。在17个临床分离株中，12个（71%）有gyrA突变，1个（6%）有gyrB突变。
相似文献
1
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.铜绿假单胞菌喹诺酮耐药菌株中DNA促旋酶突变体的比例。
Antimicrob Agents Chemother. 1990 Jun;34(6):1273-5. doi: 10.1128/AAC.34.6.1273.
2
Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.铜绿假单胞菌PAO1菌株及喹诺酮耐药临床分离株DNA促旋酶gyrA基因的克隆与核苷酸序列分析
Antimicrob Agents Chemother. 1994 Sep;38(9):1944-52. doi: 10.1128/AAC.38.9.1944.
3
Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.铜绿假单胞菌耐环丙沙星菌株中的II型拓扑异构酶突变
Antimicrob Agents Chemother. 1999 Jan;43(1):62-6. doi: 10.1128/AAC.43.1.62.
4
DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.铜绿假单胞菌喹诺酮耐药临床分离株中的DNA促旋酶gyrA突变
Antimicrob Agents Chemother. 1995 Sep;39(9):1970-2. doi: 10.1128/AAC.39.9.1970.
5
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.金黄色葡萄球菌DNA旋转酶gyrA和gyrB基因中的喹诺酮抗性突变。
Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23. doi: 10.1128/AAC.38.9.2014.
6
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.大肠杆菌DNA促旋酶gyrA基因中的喹诺酮耐药决定区。
Antimicrob Agents Chemother. 1990 Jun;34(6):1271-2. doi: 10.1128/AAC.34.6.1271.
7
Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.铜绿假单胞菌临床菌株中喹诺酮耐药机制
Microb Drug Resist. 1998 Winter;4(4):257-61. doi: 10.1089/mdr.1998.4.257.
8
Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.新型强效氟喹诺酮类药物DU-6859a的C-8取代基对其抗铜绿假单胞菌DNA旋转酶突变体活性的贡献。
Antimicrob Agents Chemother. 1995 Jul;39(7):1467-71. doi: 10.1128/AAC.39.7.1467.
9
Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.环丙沙星与氟喹诺酮类药物。作用机制与耐药性的新概念
Am J Med. 1989 Nov 30;87(5A):2S-8S. doi: 10.1016/0002-9343(89)90010-7.
10
Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.1998年和1999年分离出的耐氟喹诺酮铜绿假单胞菌临床菌株中的II型拓扑异构酶突变：靶酶在氟喹诺酮耐药机制中的作用
Antimicrob Agents Chemother. 2001 Aug;45(8):2263-8. doi: 10.1128/AAC.45.8.2263-2268.2001.
引用本文的文献
1
: Infections, Animal Modeling, and Therapeutics.感染、动物模型与治疗学
Cells. 2023 Jan 3;12(1):199. doi: 10.3390/cells12010199.
2
Evolution of Cost-Free Resistance under Fluctuating Drug Selection in .在波动的药物选择下无成本抗性的进化 于……中
mSphere. 2017 Jul 19;2(4). doi: 10.1128/mSphere.00158-17. eCollection 2017 Jul-Aug.
3
Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.囊性纤维化患者气道分离的铜绿假单胞菌抗菌药物耐药位点突变的分子流行病学
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6726-6734. doi: 10.1128/AAC.00724-16. Print 2016 Nov.
4
The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility.铜绿假单胞菌的耐药基因组与表型易感性的关系
Antimicrob Agents Chemother. 2015 Jan;59(1):427-36. doi: 10.1128/AAC.03954-14. Epub 2014 Nov 3.
5
A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry.利用定量质谱对铜绿假单胞菌PAO1全细胞的浮游和生物膜蛋白质组进行时间序列分析。
Mol Cell Proteomics. 2014 Apr;13(4):1095-105. doi: 10.1074/mcp.M113.033985. Epub 2014 Feb 16.
6
Tracking down antibiotic-resistant Pseudomonas aeruginosa isolates in a wastewater network.追踪污水管网中抗药性绿脓假单胞菌的分离株。
PLoS One. 2012;7(12):e49300. doi: 10.1371/journal.pone.0049300. Epub 2012 Dec 19.
7
Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.靶位改变和药物蓄积减少对铜绿假单胞菌氟喹诺酮类耐药性的定量贡献。
Antimicrob Agents Chemother. 2013 Mar;57(3):1361-8. doi: 10.1128/AAC.01581-12. Epub 2012 Dec 28.
8
Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa.实验进化过程中机会性病原体铜绿假单胞菌适应的基因组学研究。
PLoS Genet. 2012 Sep;8(9):e1002928. doi: 10.1371/journal.pgen.1002928. Epub 2012 Sep 13.
9
Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.嗜麦芽窄食单胞菌临床分离株中拓扑异构酶II和IV喹诺酮耐药决定区与不同水平的喹诺酮敏感性
Antimicrob Agents Chemother. 2002 Mar;46(3):665-71. doi: 10.1128/AAC.46.3.665-671.2002.
10
Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.豚鼠气单胞菌、嗜水气单胞菌和温和气单胞菌复合体的II型拓扑异构酶喹诺酮耐药决定区以及与喹诺酮耐药相关的突变
Antimicrob Agents Chemother. 2002 Feb;46(2):350-9. doi: 10.1128/AAC.46.2.350-359.2002.
本文引用的文献
1
Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.铜绿假单胞菌PAO对萘啶酸和低水平β-内酰胺类抗生素的耐药性：染色体基因图谱分析
Antimicrob Agents Chemother. 1982 Aug;22(2):242-9. doi: 10.1128/AAC.22.2.242.
2
Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.耐萘啶酸的大肠杆菌K-12突变体：基因定位与显性研究。
J Bacteriol. 1969 Jul;99(1):238-41. doi: 10.1128/jb.99.1.238-241.1969.
3
Studies on the mechanism of action of nalidixic acid.萘啶酸作用机制的研究。
Antimicrob Agents Chemother. 1973 Oct;4(4):479-86. doi: 10.1128/AAC.4.4.479.
4
Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.大肠杆菌K-12耐诺氟沙星突变体的分离与鉴定
Antimicrob Agents Chemother. 1986 Aug;30(2):248-53. doi: 10.1128/AAC.30.2.248.
5
Low- and intermediate-copy-number cloning vectors based on the Pseudomonas plasmid pVS1.
Antonie Van Leeuwenhoek. 1988;54(6):567-73. doi: 10.1007/BF00588392.
6
Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.铜绿假单胞菌中产生对诺氟沙星耐药性的突变
Antimicrob Agents Chemother. 1987 Apr;31(4):582-6. doi: 10.1128/AAC.31.4.582.
7
Mechanisms of action of and resistance to ciprofloxacin.环丙沙星的作用机制及耐药性
Am J Med. 1987 Apr 27;82(4A):12-20.
8
Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.铜绿假单胞菌PAO1及其耐萘啶酸突变体的DNA促旋酶亚基的一些特性。
J Bacteriol. 1987 May;169(5):2322-5. doi: 10.1128/jb.169.5.2322-2325.1987.
9
Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.来自耐氟喹诺酮大肠杆菌菌株的DNA促旋酶的纯化及特性
Antimicrob Agents Chemother. 1986 Nov;30(5):777-80. doi: 10.1128/AAC.30.5.777.
10
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.大肠杆菌gyrB基因的萘啶酸抗性突变
Mol Gen Genet. 1986 Sep;204(3):367-73. doi: 10.1007/BF00331012.
Zotero 插件